SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-288528
Filing Date
2020-11-09
Accepted
2020-11-09 08:02:02
Documents
14
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d799149d8k.htm   iXBRL 8-K 24847
2 EX-99.1 d799149dex991.htm EX-99.1 56392
6 GRAPHIC g799149g1107033536654.jpg GRAPHIC 7208
  Complete submission text file 0001193125-20-288528.txt   225674

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA logc-20201109.xsd EX-101.SCH 3069
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20201109_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20201109_pre.xml EX-101.PRE 11859
7 EXTRACTED XBRL INSTANCE DOCUMENT d799149d8k_htm.xml XML 3477
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38707 | Film No.: 201296172
SIC: 2836 Biological Products, (No Diagnostic Substances)